{
  "fullName": "Jeffrey L. Cummings",
  "slug": "jeffrey-l-cummings",
  "title": "MD",
  "specialty": "Alzheimer’s Drug Development",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 196,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Social-emotional agnosia, also known as emotional agnosia or expressive agnosia, is the inability to perceive facial expressions, body language, and voice intonation. A person with this disorder is unable to non-verbally perceive others' emotions in social situations, limiting normal social interactions. The condition causes a functional blindness to subtle non-verbal social-emotional cues in voice, gesture, and facial expression. People with this form of agnosia have difficulty in determining and identifying the motivational and emotional significance of external social events, and may appear emotionless or agnostic. Symptoms of this agnosia can vary depending on the area of the brain affected. Social-emotional agnosia often occurs in individuals with schizophrenia and autism. It is difficult to distinguish from, and has been found to co-occur with, alexithymia.",
  "aiSummary": "Jeffrey L. Cummings is a alzheimer’s drug development specialist with an H-index of 196 at University of Nevada, Las Vegas (Faculty). Has been published in The Lancet Neurology, The Lancet, Nature Genetics. Based in United States.",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/0/02/Jeffrey_Cummings%2C_U.S._Magistrate_Judge.png",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "University of Nevada, Las Vegas",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Alzheimer’s Drug Development"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment",
      "journal": "Journal of the American Geriatrics Society",
      "year": 2005,
      "citationCount": 24130,
      "doi": "10.1111/j.1532-5415.2005.53221.x",
      "sourceUrl": "https://doi.org/10.1111/j.1532-5415.2005.53221.x",
      "verified": true
    },
    {
      "title": "The Neuropsychiatric Inventory",
      "journal": "Neurology",
      "year": 1994,
      "citationCount": 7438,
      "doi": "10.1212/wnl.44.12.2308",
      "sourceUrl": "https://doi.org/10.1212/wnl.44.12.2308",
      "verified": true
    },
    {
      "title": "Frontotemporal lobar degeneration",
      "journal": "Neurology",
      "year": 1998,
      "citationCount": 5023,
      "doi": "10.1212/wnl.51.6.1546",
      "sourceUrl": "https://doi.org/10.1212/wnl.51.6.1546",
      "verified": true
    },
    {
      "title": "Vascular dementia",
      "journal": "Neurology",
      "year": 1993,
      "citationCount": 4862,
      "doi": "10.1212/wnl.43.2.250",
      "sourceUrl": "https://doi.org/10.1212/wnl.43.2.250",
      "verified": true
    },
    {
      "title": "Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria",
      "journal": "The Lancet Neurology",
      "year": 2007,
      "citationCount": 4346,
      "doi": "10.1016/s1474-4422(07)70178-3",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(07)70178-3",
      "verified": true
    },
    {
      "title": "Mild cognitive impairment",
      "journal": "The Lancet",
      "year": 2006,
      "citationCount": 3801,
      "doi": "10.1016/s0140-6736(06)68542-5",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(06)68542-5",
      "verified": true
    },
    {
      "title": "Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria",
      "journal": "The Lancet Neurology",
      "year": 2014,
      "citationCount": 3219,
      "doi": "10.1016/s1474-4422(14)70090-0",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(14)70090-0",
      "verified": true
    },
    {
      "title": "Clinical diagnostic criteria for dementia associated with Parkinson's disease",
      "journal": "Movement Disorders",
      "year": 2007,
      "citationCount": 2969,
      "doi": "10.1002/mds.21507",
      "sourceUrl": "https://doi.org/10.1002/mds.21507",
      "verified": true
    },
    {
      "title": "Frontal-Subcortical Circuits and Human Behavior",
      "journal": "Archives of Neurology",
      "year": 1993,
      "citationCount": 2272,
      "doi": "10.1001/archneur.1993.00540080076020",
      "sourceUrl": "https://doi.org/10.1001/archneur.1993.00540080076020",
      "verified": true
    },
    {
      "title": "Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]",
      "journal": "Neurology",
      "year": 2001,
      "citationCount": 2068,
      "doi": "10.1212/wnl.56.9.1133",
      "sourceUrl": "https://doi.org/10.1212/wnl.56.9.1133",
      "verified": true
    },
    {
      "title": "The Neuropsychiatric Inventory",
      "journal": "Neurology",
      "year": 1997,
      "citationCount": 2000,
      "doi": "10.1212/wnl.48.5_suppl_6.10s",
      "sourceUrl": "https://doi.org/10.1212/wnl.48.5_suppl_6.10s",
      "verified": true
    },
    {
      "title": "Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease",
      "journal": "Nature Genetics",
      "year": 2011,
      "citationCount": 1984,
      "doi": "10.1038/ng.801",
      "sourceUrl": "https://doi.org/10.1038/ng.801",
      "verified": true
    },
    {
      "title": "Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory",
      "journal": "Journal of Neuropsychiatry",
      "year": 2000,
      "citationCount": 1869,
      "doi": "10.1176/jnp.12.2.233",
      "sourceUrl": "https://doi.org/10.1176/jnp.12.2.233",
      "verified": true
    },
    {
      "title": "Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria",
      "journal": "Alzheimer s & Dementia",
      "year": 2016,
      "citationCount": 1845,
      "doi": "10.1016/j.jalz.2016.02.002",
      "sourceUrl": "https://doi.org/10.1016/j.jalz.2016.02.002",
      "verified": true
    },
    {
      "title": "Revising the definition of Alzheimer's disease: a new lexicon",
      "journal": "The Lancet Neurology",
      "year": 2010,
      "citationCount": 1832,
      "doi": "10.1016/s1474-4422(10)70223-4",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(10)70223-4",
      "verified": true
    },
    {
      "title": "Practice parameter: Management of dementia (an evidence-based review) [RETIRED]",
      "journal": "Neurology",
      "year": 2001,
      "citationCount": 1722,
      "doi": "10.1212/wnl.56.9.1154",
      "sourceUrl": "https://doi.org/10.1212/wnl.56.9.1154",
      "verified": true
    },
    {
      "title": "Alzheimer’s disease drug-development pipeline: few candidates, frequent failures",
      "journal": "Alzheimer s Research & Therapy",
      "year": 2014,
      "citationCount": 1702,
      "doi": "10.1186/alzrt269",
      "sourceUrl": "https://doi.org/10.1186/alzrt269",
      "verified": true
    },
    {
      "title": "Alzheimer's disease",
      "journal": "Nature Reviews Disease Primers",
      "year": 2015,
      "citationCount": 1679,
      "doi": "10.1038/nrdp.2015.56",
      "sourceUrl": "https://doi.org/10.1038/nrdp.2015.56",
      "verified": true
    },
    {
      "title": "The Amyloid-β Pathway in Alzheimer’s Disease",
      "journal": "Molecular Psychiatry",
      "year": 2021,
      "citationCount": 1612,
      "doi": "10.1038/s41380-021-01249-0",
      "sourceUrl": "https://doi.org/10.1038/s41380-021-01249-0",
      "verified": true
    },
    {
      "title": "Practice parameter: Diagnosis of dementia (an evidence-based review)",
      "journal": "Neurology",
      "year": 2001,
      "citationCount": 1395,
      "doi": "10.1212/wnl.56.9.1143",
      "sourceUrl": "https://doi.org/10.1212/wnl.56.9.1143",
      "verified": true
    },
    {
      "title": "Frontal–subcortical neuronal circuits and clinical neuropsychiatry",
      "journal": "Journal of Psychosomatic Research",
      "year": 2002,
      "citationCount": 1241,
      "doi": "10.1016/s0022-3999(02)00428-2",
      "sourceUrl": "https://doi.org/10.1016/s0022-3999(02)00428-2",
      "verified": true
    },
    {
      "title": "Alzheimer's Disease",
      "journal": "New England Journal of Medicine",
      "year": 2004,
      "citationCount": 1119,
      "doi": "10.1056/nejmra040223",
      "sourceUrl": "https://doi.org/10.1056/nejmra040223",
      "verified": true
    },
    {
      "title": "Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group",
      "journal": "The Lancet Neurology",
      "year": 2021,
      "citationCount": 959,
      "doi": "10.1016/s1474-4422(21)00066-1",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(21)00066-1",
      "verified": true
    },
    {
      "title": "The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers",
      "journal": "Alzheimer Disease & Associated Disorders",
      "year": 2006,
      "citationCount": 950,
      "doi": "10.1097/01.wad.0000213865.09806.92",
      "sourceUrl": "https://doi.org/10.1097/01.wad.0000213865.09806.92",
      "verified": true
    },
    {
      "title": "Positron Emission Tomography in Evaluation of Dementia",
      "journal": "JAMA",
      "year": 2001,
      "citationCount": 949,
      "doi": "10.1001/jama.286.17.2120",
      "sourceUrl": "https://doi.org/10.1001/jama.286.17.2120",
      "verified": true
    },
    {
      "title": "Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial",
      "journal": "The Lancet",
      "year": 2013,
      "citationCount": 925,
      "doi": "10.1016/s0140-6736(13)62106-6",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(13)62106-6",
      "verified": true
    },
    {
      "title": "The Alzheimer's Disease Centers' Uniform Data Set (UDS)",
      "journal": "Alzheimer Disease & Associated Disorders",
      "year": 2009,
      "citationCount": 881,
      "doi": "10.1097/wad.0b013e318191c7dd",
      "sourceUrl": "https://doi.org/10.1097/wad.0b013e318191c7dd",
      "verified": true
    },
    {
      "title": "Transferring R&amp;D knowledge: the key factors affecting knowledge transfer success",
      "journal": "Journal of Engineering and Technology Management",
      "year": 2003,
      "citationCount": 810,
      "doi": "10.1016/s0923-4748(03)00004-3",
      "sourceUrl": "https://doi.org/10.1016/s0923-4748(03)00004-3",
      "verified": true
    },
    {
      "title": "Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2000,
      "citationCount": 789,
      "doi": "10.1073/pnas.090106797",
      "sourceUrl": "https://doi.org/10.1073/pnas.090106797",
      "verified": true
    },
    {
      "title": "A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody",
      "journal": "Alzheimer s Research & Therapy",
      "year": 2021,
      "citationCount": 753,
      "doi": "10.1186/s13195-021-00813-8",
      "sourceUrl": "https://doi.org/10.1186/s13195-021-00813-8",
      "verified": true
    },
    {
      "title": "Frontal-subcortical circuits and neuropsychiatric disorders",
      "journal": "Journal of Neuropsychiatry",
      "year": 1994,
      "citationCount": 727,
      "doi": "10.1176/jnp.6.4.358",
      "sourceUrl": "https://doi.org/10.1176/jnp.6.4.358",
      "verified": true
    },
    {
      "title": "Alzheimer's disease drug development pipeline: 2019",
      "journal": "Alzheimer s & Dementia Translational Research & Clinical Interventions",
      "year": 2019,
      "citationCount": 722,
      "doi": "10.1016/j.trci.2019.05.008",
      "sourceUrl": "https://doi.org/10.1016/j.trci.2019.05.008",
      "verified": true
    },
    {
      "title": "Alzheimer's disease drug development pipeline: 2018",
      "journal": "Alzheimer s & Dementia Translational Research & Clinical Interventions",
      "year": 2018,
      "citationCount": 705,
      "doi": "10.1016/j.trci.2018.03.009",
      "sourceUrl": "https://doi.org/10.1016/j.trci.2018.03.009",
      "verified": true
    },
    {
      "title": "Apathy Is Not Depression",
      "journal": "Journal of Neuropsychiatry",
      "year": 1998,
      "citationCount": 673,
      "doi": "10.1176/jnp.10.3.314",
      "sourceUrl": "https://doi.org/10.1176/jnp.10.3.314",
      "verified": true
    },
    {
      "title": "Alzheimer's disease drug development pipeline: 2022",
      "journal": "Alzheimer s & Dementia Translational Research & Clinical Interventions",
      "year": 2022,
      "citationCount": 652,
      "doi": "10.1002/trc2.12295",
      "sourceUrl": "https://doi.org/10.1002/trc2.12295",
      "verified": true
    },
    {
      "title": "DNA damage is able to induce senescence in tumor cells in vitro and in vivo.",
      "journal": "PubMed",
      "year": 2002,
      "citationCount": 646,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2105571100",
      "verified": true
    },
    {
      "title": "Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease",
      "journal": "New England Journal of Medicine",
      "year": 2018,
      "citationCount": 646,
      "doi": "10.1056/nejmoa1706441",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1706441",
      "verified": true
    },
    {
      "title": "Assessing the Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: The Neuropsychiatric Inventory Caregiver Distress Scale",
      "journal": "Journal of the American Geriatrics Society",
      "year": 1998,
      "citationCount": 614,
      "doi": "10.1111/j.1532-5415.1998.tb02542.x",
      "sourceUrl": "https://doi.org/10.1111/j.1532-5415.1998.tb02542.x",
      "verified": true
    },
    {
      "title": "Frontal-subcortical circuitry and behavior",
      "journal": "Dialogues in Clinical Neuroscience",
      "year": 2007,
      "citationCount": 605,
      "doi": "10.31887/dcns.2007.9.2/rbonelli",
      "sourceUrl": "https://doi.org/10.31887/dcns.2007.9.2/rbonelli",
      "verified": true
    },
    {
      "title": "Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions",
      "journal": "Nature Genetics",
      "year": 2010,
      "citationCount": 597,
      "doi": "10.1038/ng.536",
      "sourceUrl": "https://doi.org/10.1038/ng.536",
      "verified": true
    },
    {
      "title": "In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer",
      "journal": "British Journal of Cancer",
      "year": 2002,
      "citationCount": 576,
      "doi": "10.1038/sj.bjc.6600290",
      "sourceUrl": "https://doi.org/10.1038/sj.bjc.6600290",
      "verified": true
    },
    {
      "title": "Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options",
      "journal": "Journal of Alzheimer s Disease",
      "year": 2019,
      "citationCount": 560,
      "doi": "10.3233/jad-180766",
      "sourceUrl": "https://doi.org/10.3233/jad-180766",
      "verified": true
    },
    {
      "title": "Subcortical Dementia",
      "journal": "Archives of Neurology",
      "year": 1984,
      "citationCount": 551,
      "doi": "10.1001/archneur.1984.04050190080019",
      "sourceUrl": "https://doi.org/10.1001/archneur.1984.04050190080019",
      "verified": true
    },
    {
      "title": "Conversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps",
      "journal": "Archives of Neurology",
      "year": 2006,
      "citationCount": 547,
      "doi": "10.1001/archneur.63.5.693",
      "sourceUrl": "https://doi.org/10.1001/archneur.63.5.693",
      "verified": true
    },
    {
      "title": "Alzheimer's disease drug development pipeline: 2017",
      "journal": "Alzheimer s & Dementia Translational Research & Clinical Interventions",
      "year": 2017,
      "citationCount": 538,
      "doi": "10.1016/j.trci.2017.05.002",
      "sourceUrl": "https://doi.org/10.1016/j.trci.2017.05.002",
      "verified": true
    },
    {
      "title": "Alzheimer's disease drug development pipeline: 2020",
      "journal": "Alzheimer s & Dementia Translational Research & Clinical Interventions",
      "year": 2020,
      "citationCount": 538,
      "doi": "10.1002/trc2.12050",
      "sourceUrl": "https://doi.org/10.1002/trc2.12050",
      "verified": true
    },
    {
      "title": "On the path to 2025: understanding the Alzheimer’s disease continuum",
      "journal": "Alzheimer s Research & Therapy",
      "year": 2017,
      "citationCount": 536,
      "doi": "10.1186/s13195-017-0283-5",
      "sourceUrl": "https://doi.org/10.1186/s13195-017-0283-5",
      "verified": true
    },
    {
      "title": "Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease",
      "journal": "New England Journal of Medicine",
      "year": 2019,
      "citationCount": 534,
      "doi": "10.1056/nejmoa1812840",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1812840",
      "verified": true
    },
    {
      "title": "Consensus Statement on the Upcoming Crisis in Geriatric Mental Health",
      "journal": "Archives of General Psychiatry",
      "year": 1999,
      "citationCount": 523,
      "doi": "10.1001/archpsyc.56.9.848",
      "sourceUrl": "https://doi.org/10.1001/archpsyc.56.9.848",
      "verified": true
    },
    {
      "title": "Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress",
      "journal": "Journal of Neurology Neurosurgery & Psychiatry",
      "year": 2006,
      "citationCount": 522,
      "doi": "10.1136/jnnp.2005.083113",
      "sourceUrl": "https://doi.org/10.1136/jnnp.2005.083113",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:14.000Z",
  "openalexId": "https://openalex.org/A5060487287"
}